Neuroscience
Multiple Sclerosis
100%
Relapsing Remitting Multiple Sclerosis
56%
Magnetic Resonance Imaging
21%
Brainstem
21%
Neuropathic Pain
21%
Meta-Analysis
16%
Depressive Disorder
15%
Fluoxetine
14%
Secondary Progressive Multiple Sclerosis
14%
Riluzole
14%
Behavior (Neuroscience)
14%
Brain Mapping
14%
Central Nervous System
14%
Decision-Making
14%
Amiloride
14%
Placebo
14%
Brain Imaging
13%
Expanded Disability Status Scale
13%
Gray Matter Volume
11%
Sleep Quality
10%
Gray Matter
8%
Executive Dysfunction
7%
Functional Connectivity
7%
Executive Function
7%
Mood Disorder
7%
Medicine and Dentistry
Multiple Sclerosis
29%
Cohort Analysis
28%
Diseases
15%
Systematic Review
14%
Meningitis
14%
Epileptic Seizure
14%
Myoclonus
14%
Disease Activity
14%
Motor Neuron Disease
14%
Neuroprotective Agent
14%
Decision Making
8%
Disease Course
7%
Headache
7%
Central Nervous System
7%
Brain Disease
7%
Clinical Neurology
7%
Biological Marker
7%
Disease Exacerbation
7%